NCT04453150

Brief Summary

Main aim: Study the anthropometric, metabolic, cardiovascular and neurocognitive and gut microbiota changes of different approaches for the weight reduction that increase the ketone bodies in a different proportion in relation to the classic hypocaloric diet. Objective 1: Study the effect of hypocaloric diets that increase the ketone bodies on gut microbiota and its relationship with anthropometric changes and of the Brown adipose tissue, Objective 2: with the metabolic and inflammatory changes, Objective 3: on the cardiovascular system, Objective 4: on the neurocognition, Objective 5: if they are associated to epigenetic changes that may explain the changes found in the other objectives. Objective 6: Determine the safety of the diets that increase the ketone bodies compared to the classic hypocaloric diet, Objective 7: if the effects of the different dietary approaches are maintained during the medium time, and Objective 8: Verify in experimental models (microbiota transplants from humans with different diets to germ-free mice, ketosis dietary models, and ketone bodies administration) the causality of the gut microbiota of these findings. Methodology: Model 1: Dietary intervention in humans with 4 types of diet with a different increase of the ketone bodies: classic hypocaloric diet (DH); diet with 8h of feeding and 16h of starving in periods of 24h (D16); diet with intermittent caloric restriction (DA); and normal in protein and low in carbohydrates hypocaloric ketogenic diet (DC).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable obesity

Timeline
Completed

Started Jan 2020

Typical duration for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 22, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 17, 2020

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 1, 2020

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 9, 2022

Completed
13 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 22, 2022

Completed
Last Updated

July 6, 2022

Status Verified

July 1, 2021

Enrollment Period

2.4 years

First QC Date

April 17, 2020

Last Update Submit

July 5, 2022

Conditions

Keywords

KetosisMicrobiota

Outcome Measures

Primary Outcomes (1)

  • Changes in gut microbiota composition

    To evaluate changes in gut microbiota composition from baseline using different strategies for weight loss which increase ketone bodies in comparison to a standard hypocaloric diet. Change from baseline in 16S rRNA amplicons of fecal community DNA at 3 months and 6 months

    Baseline, 12 weeks

Secondary Outcomes (10)

  • Changes in weight

    Baseline, 12 weeks

  • Changes in body mass index.

    Baseline, 12 weeks

  • Changes in waist circumference.

    Baseline, 12 weeks

  • Changes in body composition.

    Baseline, 12 weeks

  • Changes in brown adipose tissue.

    Baseline, 12 weeks

  • +5 more secondary outcomes

Study Arms (5)

Standard hypocaloric diet

EXPERIMENTAL

Mediterranean diet based on olive oil as main fat and regular consumption of vegetables (2 daily rations), fruits 3 daily rations), legumes (3 weekly rations), fish (3 weekly rations), with low consumption of red meat and meat products (less than twice a week), dairy foods (less than once a week) and no sweets, pastries or sugary drinks. Diet will produce a 600 kcal per day caloric deficit, according to the Harris-Benedict equation for each subject. Diet will include 45% carbohydrates, 35% fat, 20% protein distributed in at least 4 meals (breakfast, lunch, afternoon snack and dinner).

Other: Standard hypocaloric die

Intermittent fasting 16/8 (early fasting)

EXPERIMENTAL

Diet will produce a 600 kcal per day caloric deficit, according to the Harris-Benedict equation for each subject. Diet will include 45% carbohydrates, 35% fat, 20% protein, but it will be consumed for 8 hours a day (from 12 am. to 8 pm.), maintaining 16 fasting hours (from 8 pm. to 12 am. the following day).

Other: Intermittent fasting 16/8 (early fasting)

Intermittent fasting 16/8 (late fasting)

EXPERIMENTAL

Diet will produce a 600 kcal per day caloric deficit, according to the Harris-Benedict equation for each subject. Diet will include 45% carbohydrates, 35% fat, 20% protein, but it will be consumed for 8 hours a day (from 8 am. to 4 pm.), maintaining 16 fasting hours (from 4 pm. to 8 am. the following day).

Other: Intermittent fasting 16/8 (late fasting)

Alternate-day fasting

EXPERIMENTAL

In this diet subjects alternate norm caloric diet during 24 h (according to Harris-Benedict equation) and a diet including only 25% of caloric requirements the following 24 h (this day diet will include 5 % carbohydrates, 65% fat and 30% high biological value protein).

Other: Alternate-day fasting

Ketogenic diet

EXPERIMENTAL

Diet will produce a 600 kcal per day caloric deficit, according to the Harris-Benedict equation for each subject. Diet will include 5 % carbohydrates, 65% fat and 30% high biological value protein.

Other: Ketogenic diet

Interventions

Standard hypocaloric diet

Standard hypocaloric diet

Intermittent fasting 16/8 (early fasting)

Intermittent fasting 16/8 (early fasting)

Intermittent fasting 16/8 (late fasting)

Intermittent fasting 16/8 (late fasting)

Alternate-day fasting

Alternate-day fasting

Ketogenic diet

Ketogenic diet

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Obesity (BMI≥30-45 kg/m2)

You may not qualify if:

  • Type 2 diabetes mellitus
  • Patients with major cardiovascular events in the 6 months prior to the study beginning.
  • Previous or current history of inflammatory disease.
  • Active infectious disease.
  • The refusal of the patient to participate in the study
  • Consumption of probiotics or prebiotics
  • Antibiotic therapy in the 3 months prior to the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Virgen de la Victoria Hospital

Málaga, 29010, Spain

Location

Related Publications (2)

  • Martinez-Montoro JI, Bandera B, Gutierrez-Bedmar M, Gomez-Perez AM, Macias-Gonzalez M, Moreno-Indias I, Tinahones FJ. Effect of a ketogenic diet, time-restricted eating, or alternate-day fasting on weight loss in adults with obesity: a randomized clinical trial. BMC Med. 2025 Jul 1;23(1):368. doi: 10.1186/s12916-025-04182-z.

  • Mela V, Heras V, Iesmantaite M, Garcia-Martin ML, Bernal M, Posligua-Garcia JD, Subiri-Verdugo A, Martinez-Montoro JI, Gomez-Perez AM, Bandera B, Moreno-Indias I, Tinahones FJ. Microbiota fasting-related changes ameliorate cognitive decline in obesity and boost ex vivo microglial function through the gut-brain axis. Gut. 2025 Oct 8;74(11):1828-1846. doi: 10.1136/gutjnl-2025-335353.

MeSH Terms

Conditions

ObesityKetosis

Interventions

Diet, Ketogenic

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsAcidosisAcid-Base ImbalanceMetabolic Diseases

Intervention Hierarchy (Ancestors)

Diet, Carbohydrate-RestrictedDiet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Francisco J. Tinahones, PhD

    Instituto de Investigacion Biomedica de Malaga

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 17, 2020

First Posted

July 1, 2020

Study Start

January 22, 2020

Primary Completion

June 9, 2022

Study Completion

June 22, 2022

Last Updated

July 6, 2022

Record last verified: 2021-07

Locations